25 Jul 2017
Professor Steve Conlan, Reproductive Biology and Gynaecological Oncology, College of Medicine, Swansea University Medical School, discusses his research into the molecular and cellular mechanisms underlying ovarian cancer. Find out how Professor Conlan is working to develop a center for precision medicine, focused on his work around infertility and women’s cancer.
Reproductive Biology and Gynaecological Oncology, College of Medicine, Swansea University Medical School
Prof. Conlan leads Reproductive Biology and Gynecological Oncology research at Swansea University Medical School, investigating female health issues including endometrial (womb) and ovarian cancers, polycystic ovary syndrome (PCOS), endometriosis and in vitro fertilization (IVF). The team develop antibody-drug conjugates (ADC), nanoparticles drug delivery systems and exosomes for cancer treatment, biomarkers and nanosensors for disease diagnosis/monitoring, and investigate epigenetic/transcription disease mechanisms using Chromatrap™ technology co-developed by Porvair Ltd and Prof. Conlan’s group.